Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: A pilot study

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 2, 2011, Pages 151-156

  Palakurthi, Nikhil Kumar ^a   Correa, Zelia M ^b   Augsburger, James J ^b   Banerjee, Rupak K ^a  

^a University of Cincinnati   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABLE IMPLANT; DEVICE SAFETY; EYE TOXICITY; FOREIGN BODY REACTION; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; NONHUMAN; PILOT STUDY; SCLERA; SUSTAINED DRUG RELEASE;

ABSORBABLE IMPLANTS; ANIMALS; DELAYED-ACTION PREPARATIONS; EYE; EYE NEOPLASMS; INTRAVITREAL INJECTIONS; LYMPHOMA; METHOTREXATE; PILOT PROJECTS; RABBITS;

EID: 79954986548     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0037     Document Type: Article

References (26)

1. Barr, C.C., Green, W.R., Payne, J.W., et al. Intraocular reticulum-cell sarcoma: clinico-pathologic study of four cases and review of the literature. Surv. Ophthalmol. 19:224-239, 1975.
2. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49; 2112-2135: 1982.
3. Augsburger, J.J., and Greatrex, K.V. Intraocular lymphoma: clinical presentations, differential diagnosis and treatment. Trans. Pa. Acad. Ophthalmol. Otolaryngol. 41:796-808, 1989.
4. Walton, R.C., Onciu, M.M., Irshad, F.A., and Wilson, T.D. Conjunctival posttransplantation lymphoproliferative dis-order. Am. J. Ophthalmol. 143:1050-1051, 2007.
5. Chan, C.C., and Wallace, D.J. Intraocular lymphoma: update on diagnosis and management. Cancer Control 11:285-295, 2004. (Pubitemid 40310583)
6. Verity, D.H., Graham, E.M., Carr, R, van der Walt, J.D., and Stanford, M.R. Hypopyon uveitis and iris nodules in non-Hodgkin's lymphoma: ocular relapse during systemic re-mission. Clin. Oncol. (R. Coll. Radiol.) 12:292-294, 2000.
7. DeAngelis, L.M. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J. Neurooncol. 43:249-257, 1999.
8. de Smet, M.D. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate. Bull. Soc Belge. Ophtalmol. 279:91-95, 2001.
9. de Smet, M.D., Vancs, V.S., Kohler, D., Solomon, D., and Chan, C.C. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br. J. Ophthalmol. 83:448-451, 1999. (Pubitemid 29161187)
10. Frenkel, S., Hendler, K., Siegal, T., Shalom, E., and Pe'er, J. Intravitreal methotrexate for treating vitreoretinal lympho-ma: 10 years of experience. Br. J. Ophthalmol. 92:383-388, 2008. (Pubitemid 351363536)
11. Wang, J.K., Yang, C.M., Lin, C.P., et al. An Asian patient with intraocular lymphoma treated by intravitreal metho-trexate. Jpn. J. Ophthalmol. 50:474-478, 2006.
12. Velez, G., Yuan, P., Sung, C., et al. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch. Ophthalmol. 119:1518-1524, 2001. (Pubitemid 32963258)
13. Karma, A., von Willebrand, E.O., Tommila, P.V., et al. Pri-mary intraocular lymphoma: improving the diagnostic procedure. Ophthalmology 114:1372-1377, 2007 (Pubitemid 47001508)
14. Smith, J.R., Rosenbaum, J.T., Wilson, D.J., et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109:1709-1716, 2002. (Pubitemid 35012013)
15. Hashizoe, M., Ogura, Y., Takanashi, T., et al. Biodegradable polymeric device for sustained intravitreal release of ganci-clovir in rabbits. Curr. Eye Res. 16:633-639, 1997. (Pubitemid 27322714)
16. Kunou, N., Ogura, Y., Yasukawa, T., et al. Long-term sus-tained release of ganciclovir from biodegradable scleral im-plant for the treatment of cytomegalovirus retinitis. J. Control. Release 68:263-271, 2000. (Pubitemid 30488903)
17. Sakurai, E., Matsuda, Y., Ozeki, H., et al. Scleral plug of biodegradable polymers containing ganciclovir for experi-mental cytomegalovirus retinitis. Invest. Ophthalmol. Vis. Sci. 42:2043-2048, 2001. (Pubitemid 32726037)
18. Yasukawa, T., Ogura, Y., Sakurai, E., Tabata, Y., and Ki-mura, H. Intraocular sustained drug delivery using im-plantable polymeric devices. Adv. Drug Deliv. Rev. 57:2033-2046, 2005. (Pubitemid 41740794)
19. Bourges, J.L., Bloquel, C., Thomas, A., et al. Intraocular im-plants for extended drug delivery: therapeutic applications. Adv. Drug Deliv. Rev. 58:1182-1202, 2006. (Pubitemid 44794429)
20. Robinson, M.R., Baffi, J., Yuan, P., et al. Safety and phar-macokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. Exp. EyeRes. 74:309-317, 2002. (Pubitemid 34948406)
21. Krishnamoorthy, M.K., Park, J., Augsburger, J.J., and Banerjee, RK. Effect of retinal permeability, diffusivity, and aqueous humor hydrodynamics on pharmacokinetics of drugs in the eye. J. Ocul. Pharmacol. Ther. 24:255-267, 2008. (Pubitemid 351733225)
22. Park, J., Bungay, P.M., Lutz, R.J., et al. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. J. Control Release 105:279-295, 2005. (Pubitemid 40941993)
23. Park, J. Treatment of Intraocular Lymphoma Using Biode-gradable Microneedle Implant, 2006, Ph.D. dissertation, University of Cincinnati.
24. Park, J., Augsburger, J.J., Franco, R.S., et al. An intravitreal controlled-release micro-needle implant to treat intraocular lymphoma with 2-methoxyestradiol Proceedings of BIO2006, Summer Bioengineering Conference, BIO2006-155477, 2006.
25. Sivamani, R.K., Liepmann, D., and Maibach, H.I. Micro-needles and transdermal applications. Expert Opin. Drug Deliv. 4:19-25, 2007
26. Park, J., Franco, R.S., Augsburger, J.J., and Banerjee, R.K. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma. Curr. Eye Res. 32:659-667, 2007 (Pubitemid 47400686)